secwatch.observer — SEC 8-K summary
======================================

Issuer:     MADRIGAL PHARMACEUTICALS, INC. (MDGL)
CIK:        0001157601
Form:       8-K
Filed at:   2024-05-07T23:59:59+00:00
Accession:  0001193125-24-133196
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 1.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Madrigal announces up to $300M ATM equity offering program with TD Cowen
------------------------------------------------------------------------

- Company entered into Sales Agreement with TD Cowen to sell up to $300M of common stock via ATM.
- Prior ATM program with Cowen terminated; had generated $225.1M from 1,333,594 shares.
- Filed prospectus supplement registering up to 7,045,385 shares for selling stockholder; Madrigal receives no proceeds.
- Sales may be made through TD Cowen as agent or principal; company not obligated to sell any shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1157601/000119312524133196/0001193125-24-133196-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1157601/000119312524133196/d815387d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-133196

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer